Prime Medicine, Inc.
PRME
$1.24
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 56.53% | 6.18% | -21.55% | -15.55% | -58.61% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -64.44% | -68.74% | -61.38% | 5.55% | 677.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 550.71% | -- | -- | -- | 816.26% |
| Total Current Assets | 48.20% | 33.35% | -21.83% | -14.14% | -51.80% |
|
|
|||||
| Total Current Assets | 48.20% | 33.35% | -21.83% | -14.14% | -51.80% |
| Net Property, Plant & Equipment | 95.52% | 84.85% | 60.22% | 64.49% | -24.62% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.49% | -8.16% | -11.86% | -5.73% | -5.73% |
| Total Assets | 53.47% | 39.16% | -7.53% | -1.76% | -46.20% |
|
|
|||||
| Total Accounts Payable | -41.90% | -61.56% | -15.52% | 120.96% | 350.99% |
| Total Accrued Expenses | 15.53% | 63.08% | 7.27% | -17.34% | 13.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -61.04% | -60.03% | -61.39% | -42.63% | -20.68% |
| Total Finance Division Other Current Liabilities | -35.69% | 211.79% | 38.29% | 38.59% | 941.85% |
| Total Other Current Liabilities | -35.69% | 211.79% | 38.29% | 38.59% | 941.85% |
| Total Current Liabilities | -32.72% | -3.78% | -27.76% | 2.39% | 111.21% |
|
|
|||||
| Total Current Liabilities | -32.72% | -3.78% | -27.76% | 2.39% | 111.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 753.34% | 531.47% | 204.76% | 160.91% | -74.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 5,455.56% | 7,866.23% | -- |
| Total Liabilities | 137.51% | 217.08% | 54.84% | 77.26% | 38.00% |
|
|
|||||
| Common Stock & APIC | 34.58% | 34.63% | 28.23% | 27.69% | 2.39% |
| Retained Earnings | -39.87% | -51.50% | -57.99% | -61.49% | -67.58% |
| Treasury Stock & Other | 106.67% | 114.09% | 73.51% | 53.66% | 96.09% |
| Total Common Equity | 15.09% | -2.30% | -18.12% | -12.57% | -57.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.09% | -2.30% | -18.12% | -12.57% | -57.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.09% | -2.30% | -18.12% | -12.57% | -57.92% |
|
|
|||||